Detalhe da pesquisa
1.
Outcome of Biological Therapies and Small Molecules in Ulcerative Proctitis: A Belgian Multicenter Cohort Study.
Clin Gastroenterol Hepatol
; 22(1): 154-163.e3, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37442318
2.
Real-world Effectiveness and Safety of Risankizumab in Patients with Moderate to Severe Multirefractory Crohn's Disease: A Belgian Multicentric Cohort Study.
Inflamm Bowel Dis
; 2024 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38215029